Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A novel very rare form of pontocerebellar hypoplasia (see this term) characterized clinically by progressive microencephaly, feeding difficulties, severe developmental delay, although walking may be achieved, hypotonia often associated with increased muscle tone of lower extremities and deep tendon reflexes, joint deformities in the lower extremities, and occasionally complex seizures. PCH8 is caused by a loss-of-function mutation in the CHMP1A gene. MRI demonstrates a pontocerebellar hypoplasia with vermis and hemispheres equally affected and mild to severely reduced cerebral white matter volume with a fully formed very thin corpus callosum.
Features include always present findings: Global developmental delay and Reduced cerebral white matter volume; and very common findings: Hypoplasia of the corpus callosum and Cerebellar hypoplasia. 48 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 14 | Poor speech, Gait ataxia, Intellectual disability |
CHMP1A encodes charged multivesicular body protein 1A (196 aa). Probable peripherally associated component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. Highest expression in Testis (136.4 TPM) and Esophagus Mucosa (107.9 TPM).
Pontocerebellar hypoplasia type 8 is associated with mutations in the CHMP1A gene on chromosome 16.
The CHMP1A protein participates in HCMV Final Envelopment pathway.
CHMP1A is classified as a druggable target (Druggable Genome, Enzyme, and Neutral Zinc Metallopeptidase categories) with score 0.0.
Genetic testing for CHMP1A is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features, 2 very common features, 8 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for pontocerebellar hypoplasia type 8.
10 publications have been identified in PubMed for pontocerebellar hypoplasia type 8. Research spans Case Report / Case Series (40%), Epidemiology / Natural History (30%), and Basic Science / Preclinical (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 40% |
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 10:56 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles
4 |
Low muscle tone (hypotonia), Generalized hypotonia, Axial hypotonia |
Digestive system | 4 | Gastroesophageal reflux, Constipation, Feeding difficulties |
Head and neck | 2 | Tented upper lip vermilion, Secondary microcephaly |
Bones and joints | 2 | Joint stiffness, Sideways curvature of the spine (scoliosis) |
Heart and blood vessels | 1 | Ventricular septal defect |
Eyes | 1 | Cerebral visual impairment |
Disease patterns and progression
3 |
30% |
Laboratory research | 2 | 20% |
Research summaries | 1 | 10% |
Abdel-Salam GMH (2026). [PMID: 41436176](https://pubmed.ncbi.nlm.nih.gov/41436176/). *J Med Genet*. [Case Report / Case Series]
Drobňaková S (2026). [PMID: 42195294](https://pubmed.ncbi.nlm.nih.gov/42195294/). *Life (Basel)*. [Epidemiology / Natural History]
Kuhn A (2026). [PMID: 40665551](https://pubmed.ncbi.nlm.nih.gov/40665551/). *Dev Med Child Neurol*. [Epidemiology / Natural History]
Lertsakulbunlue S (2025). [PMID: 40661989](https://pubmed.ncbi.nlm.nih.gov/40661989/). *Case Rep Pediatr*. [Case Report / Case Series]
Liu K (2025). [PMID: 40581672](https://pubmed.ncbi.nlm.nih.gov/40581672/). *Hum Genomics*. [Basic Science / Preclinical]
Mercan M (2025). [PMID: 40085521](https://pubmed.ncbi.nlm.nih.gov/40085521/). *Amyotroph Lateral Scler Frontotemporal Degener*. [Case Report / Case Series]
van Noort SAM (2025). [PMID: 41427983](https://pubmed.ncbi.nlm.nih.gov/41427983/). *Cerebellum*. [Basic Science / Preclinical]
Xuan X (2025). [PMID: 41070650](https://pubmed.ncbi.nlm.nih.gov/41070650/). *Zhonghua Yi Xue Yi Chuan Xue Za Zhi*. [Review / Meta-Analysis]
Alayoubi AM (2024). [PMID: 39455833](https://pubmed.ncbi.nlm.nih.gov/39455833/). *Sci Rep*. [Case Report / Case Series]
Cavusoglu D (2024). [PMID: 38622473](https://pubmed.ncbi.nlm.nih.gov/38622473/). *Cerebellum*. [Epidemiology / Natural History]